Interleukin (IL)-35 is raising our expectations;Las expectativas futuras de la interleukina (IL)-35

Revista Medica de Chile

Volumn 138, Issue 6, 2010, Pages 758-766

  Ning Wei, Zhao ^a  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

Author keywords

IL 12; IL 35; Teff cells; Treg cells

Indexed keywords

EID: 77956653839     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872010000600015     Document Type: Review

References (66)

1. Devergne O, Birkenbach M, Kieff E. Epstein-Barr virusinduced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997; 94: 12041-6.
2. Yoon C, Johnston S, Tang J, Stahl M, Tobin J, Somers W. Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12. EMBO J 2000; 19: 3530-41.
3. Zhang S, Wang Q. Factors determining the formation and release of bioactive IL-12: regulatory mechanisms for IL-12p70 synthesis and inhibition. Biochem Biophys Res Commun 2008; 372: 509-12.
4. Stern AS, Podlaski FJ, Hulmes JD, Pan YC, Quinn PM, Wolitzky AG, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990; 87: 6808-12.
5. Wolf SF, Temple PA, Kobayashi M, Young D, Diciq M, Lowe L, et al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991; 146: 3074-81.
6. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, et al. Cloning and expression of murine IL-12. J Immunol 1992; 148: 3433-40.
7. Oppmann B, Lesley R, Blom B, Timans J, Xu Y, Hunte B, et al. Novel p19 protein engages IL-12 p40 to form a cytokine, IL-23, with biological activities similar as well as distinct fromIL-12. Immunity 2000; 13: 715-25.
8. Pflanz S, Timans J, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naïve CD4+ T cells. Immunity 2002; 16: 779-90.
9. Devergne O, Hummel M, Koeppen H, Le Beau MN, Nathanson EC, Kieff E, Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996; 70: 1143-53.
10. Gehlert T, Devergne O, Niedobitek G. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease. J Med Virol 2004; 73: 432-8.
11. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003; 3: 133-46.
12. Naqai H, Oniki S, Fujiwara S, Xu M, Mizoquchi I, Yoshimoto T, Nishigori C. Antitumor Activities of Interleukin-27 on Melanoma. Endocr Metab Immune Disord Drug Targets Epub ahead. 2009.
13. Goriely S, Goldman M. The Interleukin-12 Family: New Players in Transplantation Immunity? Am J Transplant 2007; 7: 278-84.
14. Wang KS, Frank DA, Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 2000; 95: 3183-90.
15. Van De Vosse E, Lichtenauer-Kaligis EGR, Van Dissel JT, Ottenhoff THM. Genetic variations in the interleukin-12/interleukin-23 receptor (β1) chain and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 2003; 54: 817-29.
16. van de Vosse E, van Dissel JT, Ottenhoff TH. Genetic deficiencies of innate immune signaling in human infectious disease. Lancet Infect Dis 2009; 9: 688-98.
17. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, et al. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R. J Immunol 2002; 168: 5699-708.
18. Yang Lijuan. The biological functions of Interleukin 27. Chin J Cell Mol Immunol 2007; 23: 1094-5.
19. Pflanz S, Hibbert L, Mattson J, Rosales R, Vaisberg E, Bazan JF, et al. WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27. J Immunol 2004; 172: 2225-31.
20. Taga T, Kishimoto T. gp130 and the Interleukin Family of cytokines. Annu Rev Immunol 1997; 15: 797-819.
21. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O. Signaling Through the Hematopoietic Cytokine Receptors. Annu Rev Immunol 1995; 13: 369-98.
22. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway1. Biochem J 1998; 334: 297-314.
23. Takaoka A, Yanai H, Kondo, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005; 434: 243-9.
24. Ouyang X, Negishia H, Takedaa R, Fujitaa Y, Taniguchia T, Honda K. Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 2007; 354: 1045-51.
25. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, et al. Evidence for licensing of IFN-γ- induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA 2006; 103: 15136-41.
26. Goriely S, Molle C, Nguyen M, Albarani V, Ouled Haddou N, Lin R, et al. Interferon regulatory factor 3 is involved in Toll-like receptor (TLR) 4- and TLR3- induced IL-12p35 gene activation. Blood 2006; 107: 1078-84.
27. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EM, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin- 12 p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435-46.
28. Liu J, Cao S, Herman LM, Ma X. Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-γ-primed IL-12 production by IFN regulatory factor 1. J Exp Med 2003; 198: 1265-76.
29. Liu JG, Guan XQ, Tamura T, Ozato K, Ma XJ. Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein. J Biol Chem 2004; 279: 55609-17.
30. Weinmann AS, Plevy SE, Smale ST. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 1999; 11: 665-75.
31. Goriely S, Demonte D, Nizet S, De Wit D, Willems F, Goldman M, Van Lint C. Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1 binding sites. Blood 2003; 101: 4894-902.
32. Goriely S, Neurath MF, Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol 2008; 8: 81-6.
33. Wirtz S, Becker C, Fantini MC, Nieuwenhuis EE, Tubbe I, Galle PR, et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-κB activation. J Immunol 2005; 174: 2814-24.
34. Wahl SM. Conversion of Peripheral CD4+CD25- Naïve T cells to CD4+CD25+ Regulatory T cells by TGF-β Induction Factor Foxp3. J Exp Med 2003; 198: 1875-86.
35. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. Cutting Edge: TGF-β induces a Regulatory Phenotype in CD4+CD25- T Cells through Foxp3 Induction and Down-Regulation of Smad7. J Immunol 2004; 172: 5149-53.
36. Guo Zheng S, Wang J, Koss MN, Quismorio F, Gray J, Horwitz DA. CD4+ and CD8+ Regulatory T Cells Generated Ex Vivo with IL-2 and TGF- Suppress a Stimulatory Graft-versus-Host Disease with a Lupus- Like Syndrome. J Immunol 2004; 172: 1531-9.
37. Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+FOXP3-T cells by T-cell receptor stimulation is transforming growth factor-β- dependent but does not confer a regulatory phenotype. Blood 2007; 110: 2983-90.
38. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007; 450: 566-9.
39. Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007; 445: 936-40.
40. Allan SE, Song-Zhao GX, Abraham T, McMurchy AN, Levings MK. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3. Eur J Immunol 2008; 38: 3282-9.
41. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 2005; 52: 2212-21.
42. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, et al. CD25+ depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003; 48: 1452-60.
43. González Rey E, Fernández Martin A, Chorny A, Delgado M. Vasoactive intestinal peptide induces CD4+CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. Arthritis Rheum 2006; 54: 864-76.
44. Niedbala W, Wei X, Cai B, Hueber AJ, Leung BP, McInnes IB, Liew FY. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007; 37: 3021-9.
45. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin-10 signaling blocks Inhibitor of B Kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274(45): 31868-74.
46. Collison LW, Pillai MR, Chaturvedi V, Vignali DA. Regulatory T Cell Suppression Is Potentiated by Target T Cells in a Cell Contact, IL-35- and IL-10-Dependent Manner. J Immunol 2009; 182: 6121-8.
47. Izcue A, Coombes J L, Powrie F. Regulatory T cellssuppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006; 212: 256-71.
48. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939-43.
49. Colgan J, Rothman P. All in the family: IL-27 suppression of TH-17 cells. Nat Immunol 2006; 7: 899-901.
50. Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of Early Protective Immunity to Viral Infection by Regulatory T Cells. Science 2008; 320: 1220-4.
51. Haribhai D, Lin W, Relland LM, Truong N, Williams CB, Chatila TA. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol 2007; 178: 2961-72.
52. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007; 8: 191-7.
53. Kassiotis G, O'Garra A. Immunity Benefits from a Little Suppression. Science 2008; 320: 1168-69.
54. Kempe S, Heinz P, Kokai E, Devergne O, Marx N, Wirth T. Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques. Am J Pathol 2009; 175: 440-7.
55. Hsieh C, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004; 21: 267-77.
56. Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 2006; 25: 249-59.
57. Almeida AR, Zaragoza B, Freitas AA. Indexation as a novel mechanism of lymphocyte homeostasis: the number of CD4+CD25+ regulatory T cells is indexed to the number of IL-2-producing cells. J Immunol 2006; 177: 192-200.
58. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-8.
59. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123-32.
60. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang Y-H, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-41.
61. Wahl SM, Wen J, Moutsopoulos N. TGF-beta: a mobile purveyor of immune privilege. Immunol Rev 2006; 213: 213-27.
62. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-76.
63. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233-40.
64. Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-33.
65. Yang J, Yang M, Min Htut T, Ouyang X, Adedayo H, Li X, et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and ROR t. Eur J Immunol 2008; 38: 1204-14.
66. Bardel E, Larousserie F, Charlot-Rabiega P, Coulomb-L'Herminé A, Devergne O. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35. J Immunol 2008; 181: 6898-905.